Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 8 studies | 24% ± 3% | |
epithelial cell | 6 studies | 30% ± 16% | |
oligodendrocyte | 5 studies | 20% ± 6% | |
classical monocyte | 4 studies | 27% ± 4% | |
glutamatergic neuron | 4 studies | 35% ± 10% | |
basal cell | 4 studies | 20% ± 2% | |
macrophage | 4 studies | 20% ± 1% | |
dendritic cell | 3 studies | 26% ± 12% | |
monocyte | 3 studies | 22% ± 4% | |
smooth muscle cell | 3 studies | 16% ± 1% | |
non-classical monocyte | 3 studies | 23% ± 5% | |
conventional dendritic cell | 3 studies | 25% ± 11% | |
retinal cone cell | 3 studies | 26% ± 3% | |
pericyte | 3 studies | 17% ± 0% | |
GABAergic neuron | 3 studies | 32% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 3777.95 | 459 / 459 | 100% | 40.70 | 1118 / 1118 |
esophagus | 100% | 4742.88 | 1445 / 1445 | 100% | 44.29 | 183 / 183 |
lung | 100% | 4830.49 | 578 / 578 | 100% | 31.61 | 1155 / 1155 |
ovary | 100% | 4085.35 | 180 / 180 | 100% | 24.08 | 430 / 430 |
prostate | 100% | 4454.71 | 245 / 245 | 100% | 32.90 | 502 / 502 |
thymus | 100% | 4636.33 | 653 / 653 | 100% | 32.94 | 605 / 605 |
uterus | 100% | 4414.16 | 170 / 170 | 100% | 32.93 | 458 / 459 |
brain | 100% | 4370.97 | 2636 / 2642 | 100% | 41.07 | 705 / 705 |
bladder | 100% | 4300.48 | 21 / 21 | 99% | 27.54 | 501 / 504 |
pancreas | 100% | 2044.09 | 327 / 328 | 99% | 24.53 | 176 / 178 |
intestine | 100% | 4903.42 | 966 / 966 | 98% | 23.12 | 518 / 527 |
kidney | 100% | 2997.35 | 89 / 89 | 98% | 28.12 | 884 / 901 |
stomach | 100% | 3189.17 | 359 / 359 | 97% | 24.79 | 278 / 286 |
adrenal gland | 100% | 2734.67 | 258 / 258 | 96% | 19.17 | 221 / 230 |
skin | 100% | 4953.13 | 1809 / 1809 | 95% | 30.09 | 449 / 472 |
liver | 100% | 1542.90 | 226 / 226 | 84% | 10.96 | 343 / 406 |
adipose | 100% | 3835.17 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3747.98 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 3158.63 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3746.67 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 34.08 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.96 | 1 / 1 |
heart | 98% | 2272.48 | 844 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 21.71 | 28 / 29 |
peripheral blood | 88% | 2562.80 | 814 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 81% | 13.81 | 65 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0017148 | Biological process | negative regulation of translation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045637 | Biological process | regulation of myeloid cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003723 | Molecular function | RNA binding |
GO_0000900 | Molecular function | mRNA regulatory element binding translation repressor activity |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0032422 | Molecular function | purine-rich negative regulatory element binding |
GO_0046332 | Molecular function | SMAD binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0003697 | Molecular function | single-stranded DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0003729 | Molecular function | mRNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
Gene name | PURB |
Protein name | Transcriptional regulator protein Pur-beta (Purine-rich element-binding protein B) |
Synonyms | |
Description | FUNCTION: Transcriptional regulator which can act as an activator or a repressor. Represses the transcription of ACTA2 in fibroblasts and smooth muscle cells via its ability to interact with the purine-rich strand of a MCAT- containing element in the 5' flanking region of the gene. Represses the transcription of MYOCD, capable of repressing all isoforms of MYOCD but the magnitude of the repressive effects is most notable for the SMC- specific isoforms. Promotes hepatic glucose production by activating the transcription of ADCY6, leading to cAMP accumulation, increased PKA activity, CREB activation, and increased transcription of PCK1 and G6PC genes (By similarity). Has capacity to bind repeated elements in single-stranded DNA such as the purine-rich single strand of the PUR element located upstream of the MYC gene . Participates in transcriptional and translational regulation of alpha-MHC expression in cardiac myocytes by binding to the purine-rich negative regulatory (PNR) element Modulates constitutive liver galectin-3 gene transcription by binding to its promoter. May play a role in the dendritic transport of a subset of mRNAs (By similarity). . |
Accessions | ENST00000395699.5 Q96QR8 |